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Abstract
Background: Undifferentiated embryonal sarcoma of the liver (UESL) is a rare malignant mesenchymal tumor that
usually occurs in children and is rarely diagnosed in adults.
Case presentation: Here, we describe the case of a 65-year-old woman who presented with a huge cystic lesion in
the liver. Laboratory studies performed on admission showed modest inflammation, poor nutrition, and elevated levels
of total bilirubin, alkaline phosphatase, and γ-glutamyl transferase. Computed tomography showed a well-defined,
heterogeneous tumor with multiple cysts involving the right lobe and the medial segment of the liver, with a maximum
diameter of 16 cm. Positron emission tomography/computed tomographic scans showed the uptake of 2-(fluorine-18)-
fluoro-2-deoxy-D-glucose in a part of the cyst. The patient was diagnosed with mucinous cystadenocarcinoma or sarcoma
of the liver and underwent right trisectionectomy. Histopathological studies revealed that the tumor was composed of
pleomorphic and polynuclear dyskaryotic cells with eosinophilic globules in the cytoplasm. Mesenchymal hamartoma-like
tissue was observed in the peripheral part of the tumor. Immunohistochemical analyses showed the tumor stained with
vimentin, α-smooth muscle actin, desmin, α1-antitrypsin, and α1-antichymotripsin. Therefore, a histological diagnosis of
UESL was made. Eighteen months following treatment, two recurrent tumors in the remnant liver were detected and
resection of the recurrent tumors was performed.
Conclusions: A UESL should be considered in the differential diagnosis of large cystic hepatic lesions. Although the
prognosis of UESL is extremely unfavorable, aggressive surgical resection should be the most important factor for
ensuring long-term survival.
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Background
Undifferentiated embryonal sarcoma of the liver (UESL)
is a rare and aggressive malignant tumor that is observed
predominantly in children [1]. To the best of our know-
ledge, fewer than 40 cases of UESL have been reported
in patients older than 20 years over the past 50 years [2].
Therefore, it is important to consider this entity in the
differential diagnosis of a large hepatic mass. The patho-
logical features of UESL are poorly understood. A link
between UESL and mesenchymal hamartoma of the liver
(MHL) has been proposed because of the overlapping
clinicopathological features of these entities [3]. In this
report, we describe a case of UESL in an adult with
historical features of an MHL-like lesion that had a good
prognosis with complete resection.
Case presentation
A 65-year-old woman presented to our hospital for
further examination of a large hepatic tumor that has
been detected on abdominal computed tomography
(CT) performed at another hospital to evaluate right
dorsal pain. Laboratory studies showed slightly increased
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values of hepatobiliary enzymes, including total bilirubin
(1.3 mg/dL), alkaline phosphatase (452 IU/L), and γ-
glutamyl transferase (167 IU/L). The indocyanine green
plasma disappearance rate (0.103) and 15-min retention
rate (23.9%) suggested depressed liver function. Tests for
serum hepatitis B and C viral markers were negative.
The levels of α-fetoprotein (AFP), protein induced by
vitamin K absence-II (PIVKA-II), carcinoembryonic anti-
gen (CEA), and carbohydrate antigen 19-9 (CA19-9)
were all within normal limits, whereas elevated values
were observed for Duke pancreatic monoclonal antigen
type 2 (DUPAN-2; 200 U/mL), cancer antigen 125
(CA125; 321.8 U/mL), and neuron specific enolase (NSE;
29.2 ng/mL). Abdominal CT revealed a well-defined, low-
density, heterogeneous, multilocular, cystic tumor with
septa replacing the right hepatic lobe and the medial seg-
ment of the left hepatic lobe, measuring 16 cm in max-
imum diameter. The large tumor contained an enhancing
solid compartment and a non-enhancing cystic compart-
ment. It compressed the umbilical portion of the portal
vein, the right portal vein, and the left hepatic vein (Fig. 1).
Magnetic resonance imaging (MRI) showed a mixed in-
tensity of high and low signals. The cysts had low signal
intensity on T1-weighted images and had high signal in-
tensity on T2-weighted images, suggesting high water
content. Furthermore, areas with partially high signal in-
tensity on T1-weighted images and low signal intensity on
T2-weighted images were suggestive of intratumoral
hemorrhage (Fig. 2). Abdominal ultrasonography (US)
showed a honeycomb-like tumor with solid components
(Fig. 3a). Positron emission tomography (PET) showed the
uptake of 2-(fluorine-18)-fluoro-2-deoxy-D-glucose (FDG)
in part of the solid components of the cyst (Fig. 3b). From
these imaging findings, the preoperative diagnosis of mu-
cinous cystadenocarcinoma or sarcoma of the liver was
made. As the right hepatic lobe was occupied by the large
tumor and the percentage of the future remnant liver
volume in right hepatic trisectionectomy was 52.3%, we
did not perform preoperative portal vein embolization.
After nutritional therapy, the indocyanine green plasma
disappearance rate (0.150) and 15-min retention rate
(11.9%) were recovered. We decided to perform right
trisectionectomy with caudate lobectomy. An inverted T-
shaped incision with thoracotomy along the ninth intercos-
tal space was performed. Intraoperative findings revealed
that the large tumor was well circumscribed and showed
no invasion of vessels, so bile duct resection and vascular
resection were not performed. The right hepatic artery and
the right portal vein were divided and ligated. After
mobilization of the right liver, a number of short hepatic
veins were also ligated and divided. The right and middle
hepatic veins were dissected and ligated with an Endo
GIA. We then divided the liver parenchyma with a Pringle
maneuver. Because lymph node swelling was not observed,
a regional lymph node dissection was not performed.
Operation time was 364 min and total blood loss was
2521 ml. The resected specimen showed a heterogenic
tumor measuring 19 × 17 × 13 cm. The cut surface of the
specimen revealed a multilocular mass with the various
components of hemorrhage, necrosis, and a mucinous
Fig. 1 Abdominal CT revealed a huge tumor. A well-defined, low-density, heterogeneous, multilocular, cystic tumor with septa involved the right
lobe and the medial segment of the liver (a). The tumor compressed the umbilical portion of the portal vein (b), the right portal vein (c), and the
left hepatic vein (d)
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substance. Microscopically, the tumor was composed of
pleomorphic and polynuclear dyskaryotic cells with eosino-
philic globules in its cytoplasm, which were diastase-
resistant Periodic acid–Schiff (PAS) positive. The area of
FDG uptake in PET was mainly consistent with viable
tumor cells. In the peripheral part of the area, mesenchy-
mal hamartoma-like lesions consisting of loose myxoid
stroma and non-atypical spindle cells were observed
(Fig. 4). No vascular invasion or intrahepatic metastases
were detected. The surgical margin was free (R0). Accord-
ing to immunohistochemistry, the tumor was positive for
vimentin, α1-antitrypsin, and α1-antichymotripsin. Some
tumor cells also expressed desmin and α-smooth muscle
actin (Fig. 5). On the basis of these findings, the tumor was
histologically diagnosed as UESL. After surgery, the patient
did not receive adjuvant chemotherapy and has been
followed with imaging studies, including a whole-body CT
and PET scan. Eighteen months following treatment, recur-
rent tumors in the remnant liver were detected in S3 and
partial resection of the liver was performed. Microscopic-
ally, the tumors consisted of atypical cells with irregular
nuclei and polynuclear dyskaryotic cells with eosinophilic
globules in the cytoplasm, which were diastase-resistant
PAS positive (Fig. 6a–c). By immunohistochemistry, these
atypical cells stained with α1-antitrypsin (Fig. 6d). Findings
indicated recurrent UESL. Moreover, a part of the tumor
consisted of a loose edematous matrix populated by
spindle or stellate-shaped cells with bile ducts and small
cystic spaces, which was reminiscent of a mesenchymal
hamartoma. The patient is currently alive 26 months fol-
lowing the first operation and has no recurrent tumor.
Discussion
UESL is a relatively new clinicopathologic entity that
was first described in 1978 by Stocker and Ishak [4]. It is
found most frequently in children between 6 and
10 years of age [4] but has been rarely reported in adults.
There have been 46 articles regarding adult UESL pub-
lished from 1977 to 2015 [5]. UESL accounts for fewer
than 1% of all primary liver neoplasms in adults [1]. In a
recent review on UESL, the median age of the study
group was 25, with the oldest patient being 86 years old
[6]. In most cases, symptoms related to the tumor are
nonspecific, with abdominal pain and abdominal mass
reported to be the most common presenting complaints
[2, 7, 8]. There are no specific tumor markers. Further-
more, the results of imaging studies such as CT, US, and
MRI are often inconclusive [1]. On US, UESL usually ap-
pears as a hypoechoic solid mass [9]. CT characteristics
include the presence of an enhanced peripheral rim,
some solid portions at the periphery or adjacent to the
septa, and a predominantly unilocular or multilocular
appearance [9, 10]. These features occasionally lead to
this tumor being misdiagnosed as a benign cystic lesion.
Fig. 2 MRI revealed high and low signal intensity in T1-weighted images (a) and high signal intensity in T2-weighted images (b)
Fig. 3 Abdominal US revealed a honeycomb pattern in the tumor, with solid components (a). PET-CT showed the uptake of FDG in the solid
components of the cyst (b)
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In this case, because of its multilocular cystic appearance
on CT imaging, mucinous cystadenocarcinoma of the
liver should be considered in the differential diagnosis.
In addition, since UESL in adulthood is very rare, it was
extremely difficult in this case to make a preoperative
diagnosis. However, the intermixed appearance of
hemorrhage and mucinous content on MRI and the
honeycomb appearance with solid components on US
studies were the characteristics of UESL. The discrep-
ancy between the solid appearance on US and cystic
appearance on CT in particular should raise suspicion
for this tumor [9].
The prognosis of UESL is very poor, with a median re-
ported survival time of less than 1 year [4]. Some case
reports and studies demonstrated long-term survival of
patients who underwent only surgery [11]. However,
even if a complete resection is achieved in surgery, UESL
recurs in many cases [6]. Lenze et al. reviewed reports
from 1955 to 2007 and reported that the combination of
surgical resection and adjuvant chemotherapy may
improve prognosis compared with radical tumor resec-
tion alone [6]. Although there were no standard regi-
mens for adjuvant chemotherapy, a sarcoma-directed
chemotherapy such as combination of vincristine, acti-
nomycin, ifosfamide, and doxorubicin or combination of
carboplatin and etoposide was used [1, 6]. In addition,
multidisciplinary therapy such as chemotherapy, radio-
therapy, interventional therapy, and transplantation may
be helpful for improving survival for unresectable recur-
rent tumors [12]. However, adjuvant chemotherapy was
not administered to our patient because there were no
standard regimens for UESL. Repeat complete resection
Fig. 4 Pathological findings of the tumor. Macroscopically, the cut surface revealed a multilocular mass with areas of hemorrhage, necrosis, and a
mucinous substance (a). Microscopically, the tumor was composed of pleomorphic and polynuclear dyskaryotic cells, and mesenchymal hamartoma-
like lesions were partially seen (hematoxylin and eosin stain) (b). The cytoplasm of the polynuclear dyskaryotic cell contained eosinophilic globules that
were diastase-resistant PAS positive (PAS stain) (c)
Fig. 5 Immunohistochemical analysis showed that the tumor was stained with vimentin (a), α1-antitrypsin (b), desmin (c), and α-smooth muscle
actin (d)
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for recurrent tumor was performed, and now, the pa-
tient has no recurrent tumor after 26 months following
the first operation.
The pathological features of UESL are poorly understood.
In the case reported here, mesenchymal hamartoma-like
lesions were partially observed. Several authors have sug-
gested an evolutive histological spectrum between MHL
and UESL, based on histological findings [13, 14]. However,
the occurrence of MHL in adults is also very rare. Further-
more, there are some reports of a benign postoperative
course of MHL after incomplete resection [15–19]. In the
liver metastatic lesion of this case, there were some mesen-
chymal hamartoma-like lesions. A UESL-like lesion and a
mesenchymal hamartoma-like lesion coexisted not only in
the primary tumor but also in the metastatic tumor, sug-
gesting that a mixed mesenchymal hamartoma-like lesion
is one form of UESL, rather than a malignant transform-
ation of MHL. Further investigation is needed to clarify the
pathogenesis and relationship of MHL and UESL.
Conclusions
It is important to achieve accurate and early diagnosis
of UESL and include it in the differential diagnosis of
large liver masses, regardless of the patient’s age.
Although UESL is an aggressive tumor with a poor prog-
nosis, the patient reported herein experienced a good sur-
vival through aggressive liver resection, including repeat
hepatectomy. Therefore, complete resection should be the
most important factor for ensuring long-term survival.
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